Business Description
Biomind Labs Inc
NAICS : 541714
SIC : 3741
ISIN : CA0907021012
Compare
Compare
Traded in other countries / regions
BMND.CanadaBMNDF.USA3XI.Germany IPO Date
2021-07-28Description
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -32.06 | |||||
Debt-to-Equity | -0.56 | |||||
Debt-to-EBITDA | -2.24 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.88 | |||||
9-Day RSI | 38.83 | |||||
14-Day RSI | 42.86 | |||||
6-1 Month Momentum % | 491.3 | |||||
12-1 Month Momentum % | 134.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Cash Ratio | 0.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -4.16 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -846.15 | |||||
ROIC % | -48.04 | |||||
ROC (Joel Greenblatt) % | -1684.21 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -46.5 | |||||
EV-to-EBITDA | -47.24 | |||||
EV-to-FCF | -45.37 | |||||
Earnings Yield (Greenblatt) % | -2.15 | |||||
FCF Yield % | -2.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biomind Labs Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.022 | ||
Beta | 2.67 | ||
Volatility % | 265.96 | ||
14-Day RSI | 42.86 | ||
14-Day ATR (C$) | 0.108158 | ||
20-Day SMA (C$) | 0.54825 | ||
12-1 Month Momentum % | 134.48 | ||
52-Week Range (C$) | 0.025 - 1.09 | ||
Shares Outstanding (Mil) | 74.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biomind Labs Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biomind Labs Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Biomind Labs Inc Frequently Asked Questions
What is Biomind Labs Inc(NEOE:BMND)'s stock price today?
The current price of NEOE:BMND is C$0.38. The 52 week high of NEOE:BMND is C$1.09 and 52 week low is C$0.03.
When is next earnings date of Biomind Labs Inc(NEOE:BMND)?
The next earnings date of Biomind Labs Inc(NEOE:BMND) is .
Does Biomind Labs Inc(NEOE:BMND) pay dividends? If so, how much?
Biomind Labs Inc(NEOE:BMND) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |